Michael Ewers
Michael Ewers
Institute for Stroke and Dementia Research, Ludwig Maximilian University Munich (LMU)
Zweryfikowany adres z med.uni-muenchen.de
Cytowane przez
Cytowane przez
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
Jama 302 (4), 385-393, 2009
Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance
Y Stern, EM Arenaza‐Urquijo, D Bartrés‐Faz, S Belleville, M Cantilon, ...
Alzheimer's & Dementia 16 (9), 1305-1311, 2020
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
K Buerger, M Ewers, T Pirttilä, R Zinkowski, I Alafuzoff, SJ Teipel, ...
Brain 129 (11), 3035-3041, 2006
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
K Jekel, M Damian, C Wattmo, L Hausner, R Bullock, PJ Connelly, ...
Alzheimer's research & therapy 7 (1), 1-20, 2015
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance
M Ewers, C Walsh, JQ Trojanowski, LM Shaw, RC Petersen, CR Jack Jr, ...
Neurobiology of aging 33 (7), 1203-1214. e2, 2012
Implementation of subjective cognitive decline criteria in research studies
JL Molinuevo, LA Rabin, R Amariglio, R Buckley, B Dubois, KA Ellis, ...
Alzheimer's & Dementia 13 (3), 296-311, 2017
sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ...
EMBO molecular medicine 8 (5), 466-476, 2016
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
H Hampel, M Ewers, K Burger, P Annas, A Mortberg, A Bogstedt, L Frolich, ...
Journal of Clinical Psychiatry 70 (6), 922, 2009
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
M Ewers, RA Sperling, WE Klunk, MW Weiner, H Hampel
Trends in neurosciences 34 (8), 430-442, 2011
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease
C Plant, SJ Teipel, A Oswald, C Böhm, T Meindl, J Mourao-Miranda, ...
Neuroimage 50 (1), 162-174, 2010
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment
SJ Teipel, C Born, M Ewers, ALW Bokde, MF Reiser, HJ Möller, H Hampel
Neuroimage 38 (1), 13-24, 2007
Levels of β-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment
Z Zhong, M Ewers, S Teipel, K Bürger, A Wallin, K Blennow, P He, ...
Archives of general psychiatry 64 (6), 718-726, 2007
A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms
E Baykara, B Gesierich, R Adam, AM Tuladhar, JM Biesbroek, HL Koek, ...
Annals of neurology 80 (4), 581-592, 2016
Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury
M Suárez-Calvet, MÁ Araque Caballero, G Kleinberger, RJ Bateman, ...
Science translational medicine 8 (369), 369ra178-369ra178, 2016
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need
GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ...
Alzheimer's & Dementia 15 (2), 292-312, 2019
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
M Ewers, K Buerger, SJ Teipel, P Scheltens, J Schröder, RP Zinkowski, ...
Neurology 69 (24), 2205-2212, 2007
Age and diagnostic performance of Alzheimer disease CSF biomarkers
N Mattsson, E Rosen, O Hansson, N Andreasen, L Parnetti, M Jonsson, ...
Neurology 78 (7), 468-476, 2012
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
N Franzmeier, J Neitzel, A Rubinski, R Smith, O Strandberg, ...
Nature communications 11 (1), 347, 2020
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
M Ewers, N Franzmeier, M Suárez-Calvet, E Morenas-Rodriguez, ...
Science translational medicine 11 (507), eaav6221, 2019
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20